Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Hyponatremia and the risk of kidney stones: A matched case-control study in a large U.S. health system.

Tominaga N, Fernandez SJ, Mete M, Shara NM, Verbalis JG.

PLoS One. 2018 Sep 21;13(9):e0203942. doi: 10.1371/journal.pone.0203942. eCollection 2018.

2.

Subdiaphragmatic Vagotomy With Pyloroplasty Ameliorates the Obesity Caused by Genetic Deletion of the Melanocortin 4 Receptor in the Mouse.

Dezfuli G, Gillis RA, Tatge JE, Duncan KR, Dretchen KL, Jackson PG, Verbalis JG, Sahibzada N.

Front Neurosci. 2018 Mar 1;12:104. doi: 10.3389/fnins.2018.00104. eCollection 2018.

3.

Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study.

Winther JA, Brynildsen J, Høiseth AD, Følling I, Brekke PH, Christensen G, Hagve TA, Verbalis JG, Omland T, Røsjø H.

PLoS One. 2016 Aug 16;11(8):e0161232. doi: 10.1371/journal.pone.0161232. eCollection 2016.

4.

Correction: Hyponatremia Improvement Is Associated with a Reduced Risk of Mortality: Evidence from a Meta-Analysis.

Corona G, Giuliani C, Verbalis JG, Forti G, Maggi M, Peri A.

PLoS One. 2016 Mar 28;11(3):e0152846. doi: 10.1371/journal.pone.0152846. eCollection 2016. No abstract available.

5.

Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.

Lee MR, Wehring HJ, McMahon RP, Liu F, Linthicum J, Verbalis JG, Buchanan RW, Strauss GP, Rubin LH, Kelly DL.

Schizophr Res. 2016 Apr;172(1-3):165-8. doi: 10.1016/j.schres.2016.02.014. Epub 2016 Feb 12.

6.

Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT).

Verbalis JG, Ellison H, Hobart M, Krasa H, Ouyang J, Czerwiec FS; Investigation of the Neurocognitive Impact of Sodium Improvement in Geriatric Hyponatremia: Efficacy and Safety of Tolvaptan (INSIGHT) Investigators.

Am J Kidney Dis. 2016 Jun;67(6):893-901. doi: 10.1053/j.ajkd.2015.12.024. Epub 2016 Feb 11.

PMID:
26874645
7.

Aging-related impairment of urine-concentrating mechanisms correlates with dysregulation of adrenocortical angiotensin type 1 receptors in male Fischer rats.

Ji H, Zheng W, Wu X, Speth RC, Verbalis JG, Stein LM, Yosten GL, Samson WK, Sandberg K.

Am J Physiol Regul Integr Comp Physiol. 2016 Mar 15;310(6):R513-21. doi: 10.1152/ajpregu.00131.2015. Epub 2015 Dec 23.

8.

Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.

Verbalis JG, Greenberg A, Burst V, Haymann JP, Johannsson G, Peri A, Poch E, Chiodo JA 3rd, Dave J.

Am J Med. 2016 May;129(5):537.e9-537.e23. doi: 10.1016/j.amjmed.2015.11.005. Epub 2015 Nov 14.

PMID:
26584969
9.

Hyponatremia in Neurotrauma: The Role of Vasopressin.

Kleindienst A, Hannon MJ, Buchfelder M, Verbalis JG.

J Neurotrauma. 2016 Apr 1;33(7):615-24. doi: 10.1089/neu.2015.3981. Epub 2015 Dec 23. Review.

PMID:
26472056
10.

Statement of the 3rd International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015.

Hew-Butler T, Rosner MH, Fowkes-Godek S, Dugas JP, Hoffman MD, Lewis DP, Maughan RJ, Miller KC, Montain SJ, Rehrer NJ, Roberts WO, Rogers IR, Siegel AJ, Stuempfle KJ, Winger JM, Verbalis JG.

Br J Sports Med. 2015 Nov;49(22):1432-46. doi: 10.1136/bjsports-2015-095004. Epub 2015 Jul 30. No abstract available.

PMID:
26227507
11.

Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015.

Hew-Butler T, Rosner MH, Fowkes-Godek S, Dugas JP, Hoffman MD, Lewis DP, Maughan RJ, Miller KC, Montain SJ, Rehrer NJ, Roberts WO, Rogers IR, Siegel AJ, Stuempfle KJ, Winger JM, Verbalis JG.

Clin J Sport Med. 2015 Jul;25(4):303-20. doi: 10.1097/JSM.0000000000000221. No abstract available.

PMID:
26102445
12.

Hyponatremia Is Associated With Increased Osteoporosis and Bone Fractures in a Large US Health System Population.

Usala RL, Fernandez SJ, Mete M, Cowen L, Shara NM, Barsony J, Verbalis JG.

J Clin Endocrinol Metab. 2015 Aug;100(8):3021-31. doi: 10.1210/jc.2015-1261. Epub 2015 Jun 17.

13.

Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis.

Corona G, Giuliani C, Verbalis JG, Forti G, Maggi M, Peri A.

PLoS One. 2015 Apr 23;10(4):e0124105. doi: 10.1371/journal.pone.0124105. eCollection 2015. Erratum in: PLoS One. 2016;11(3):e0152846.

14.

Current treatment practice and outcomes. Report of the hyponatremia registry.

Greenberg A, Verbalis JG, Amin AN, Burst VR, Chiodo JA 3rd, Chiong JR, Dasta JF, Friend KE, Hauptman PJ, Peri A, Sigal SH.

Kidney Int. 2015 Jul;88(1):167-77. doi: 10.1038/ki.2015.4. Epub 2015 Feb 11.

15.

Disorders of water metabolism: diabetes insipidus and the syndrome of inappropriate antidiuretic hormone secretion.

Verbalis JG.

Handb Clin Neurol. 2014;124:37-52. doi: 10.1016/B978-0-444-59602-4.00003-4. Review.

PMID:
25248578
16.

The reply.

Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, Thompson CJ.

Am J Med. 2014 Jul;127(7):e31-2. doi: 10.1016/j.amjmed.2014.03.022. No abstract available.

PMID:
24970609
17.

Sex and basic science. A Title IX position.

Sandberg K, Verbalis JG, Yosten GL, Samson WK.

Am J Physiol Regul Integr Comp Physiol. 2014 Aug 15;307(4):R361-5. doi: 10.1152/ajpregu.00251.2014. Epub 2014 Jun 18. No abstract available.

18.

Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise.

Hew-Butler T, Hummel J, Rider BC, Verbalis JG.

Am J Physiol Regul Integr Comp Physiol. 2014 Aug 15;307(4):R366-75. doi: 10.1152/ajpregu.00120.2014. Epub 2014 Jun 18.

19.

Sodium homeostasis and bone.

Hannon MJ, Verbalis JG.

Curr Opin Nephrol Hypertens. 2014 Jul;23(4):370-6. doi: 10.1097/01.mnh.0000447022.51722.f4. Review.

PMID:
24840297
20.

Review and analysis of differing regulatory indications and expert panel guidelines for the treatment of hyponatremia.

Verbalis JG, Grossman A, Höybye C, Runkle I.

Curr Med Res Opin. 2014 Jul;30(7):1201-7. doi: 10.1185/03007995.2014.920314. Epub 2014 May 14. Review.

PMID:
24809970
21.

Renal physiology of nocturia.

Verbalis JG.

Neurourol Urodyn. 2014 Apr;33 Suppl 1:S6-9. doi: 10.1002/nau.22594. Review.

PMID:
24729151
22.

Hyponatremia with intracranial disease: not often cerebral salt wasting.

Verbalis JG.

J Clin Endocrinol Metab. 2014 Jan;99(1):59-62. doi: 10.1210/jc.2013-4289. No abstract available.

PMID:
24384014
23.

Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis.

Corona G, Giuliani C, Parenti G, Norello D, Verbalis JG, Forti G, Maggi M, Peri A.

PLoS One. 2013 Dec 18;8(12):e80451. doi: 10.1371/journal.pone.0080451. eCollection 2013.

24.

Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases.

Laville M, Burst V, Peri A, Verbalis JG.

Clin Kidney J. 2013 Nov;6(Suppl 1):i1-i20. doi: 10.1093/ckj/sft113.

25.

Efficacy of oral versus intravenous hypertonic saline in runners with hyponatremia.

Owen BE, Rogers IR, Hoffman MD, Stuempfle KJ, Lewis D, Fogard K, Verbalis JG, Hew-Butler T.

J Sci Med Sport. 2014 Sep;17(5):457-62. doi: 10.1016/j.jsams.2013.09.001. Epub 2013 Sep 18.

PMID:
24148616
26.

Models of interinstitutional partnerships between research intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) consortium.

Ofili EO, Fair A, Norris K, Verbalis JG, Poland R, Bernard G, Stephens DS, Dubinett SM, Imperato-McGinley J, Dottin RP, Pulley J, West A, Brown A, Mellman TA.

Clin Transl Sci. 2013 Dec;6(6):435-43. doi: 10.1111/cts.12118. Epub 2013 Oct 3.

27.

Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.

Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, Thompson CJ.

Am J Med. 2013 Oct;126(10 Suppl 1):S1-42. doi: 10.1016/j.amjmed.2013.07.006.

PMID:
24074529
28.

Melanocortin signaling in the brainstem influences vagal outflow to the stomach.

Richardson J, Cruz MT, Majumdar U, Lewin A, Kingsbury KA, Dezfuli G, Vicini S, Verbalis JG, Dretchen KL, Gillis RA, Sahibzada N.

J Neurosci. 2013 Aug 14;33(33):13286-99. doi: 10.1523/JNEUROSCI.0780-13.2013.

29.

The need for salt: does a relationship exist between cystic fibrosis and exercise-associated hyponatremia?

Lewis DP, Hoffman MD, Stuempfle KJ, Owen BE, Rogers IR, Verbalis JG, Hew-Butler TD.

J Strength Cond Res. 2014 Mar;28(3):807-13. doi: 10.1519/JSC.0b013e3182a35dbd.

PMID:
23897018
30.

Sex and the basic scientist: is it time to embrace Title IX?

Sandberg K, Verbalis JG.

Biol Sex Differ. 2013 Jul 27;4(1):13. doi: 10.1186/2042-6410-4-13. No abstract available.

31.

Age-associated abnormalities of water homeostasis.

Cowen LE, Hodak SP, Verbalis JG.

Endocrinol Metab Clin North Am. 2013 Jun;42(2):349-70. doi: 10.1016/j.ecl.2013.02.005. Epub 2013 Apr 17. Review.

32.

Development of an experimental model to study the pathophysiology of cerebral salt wasting following subarachnoid hemorrhage.

Kleindienst A, Schlaffer SM, Sharma N, Linde L, Buchfelder M, Verbalis JG.

Acta Neurochir Suppl. 2012;114:399-403. doi: 10.1007/978-3-7091-0956-4_77.

PMID:
22327731
33.

Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats.

Barsony J, Manigrasso MB, Xu Q, Tam H, Verbalis JG.

Age (Dordr). 2013 Apr;35(2):271-88. doi: 10.1007/s11357-011-9347-9. Epub 2012 Jan 5.

34.

Changes in steroid concentrations with the timing of corticotropin stimulation testing in participants with adrenal sufficiency.

Jonklaas J, Holst JP, Verbalis JG, Pehlivanova M, Soldin SJ.

Endocr Pract. 2012 Jan-Feb;18(1):66-75. doi: 10.4158/EP11085.OR.

35.

Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia.

Hew-Butler T, Hoffman MD, Stuempfle KJ, Rogers IR, Morgenthaler NG, Verbalis JG.

Clin J Sport Med. 2011 May;21(3):211-7. doi: 10.1097/JSM.0b013e31821a62c2.

36.

Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion.

Verbalis JG, Adler S, Schrier RW, Berl T, Zhao Q, Czerwiec FS; SALT Investigators.

Eur J Endocrinol. 2011 May;164(5):725-32. doi: 10.1530/EJE-10-1078. Epub 2011 Feb 11.

37.

Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion.

Verbalis JG.

J Hosp Med. 2010 Jul-Aug;5 Suppl 3:S18-26. doi: 10.1002/jhm.783. Review.

PMID:
21157906
38.

Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study.

Aronson D, Verbalis JG, Mueller M, Krum H; DILIPO investigators.

Eur J Heart Fail. 2011 Mar;13(3):327-36. doi: 10.1093/eurjhf/hfq226. Epub 2011 Jan 3.

39.

Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss.

Barsony J, Sugimura Y, Verbalis JG.

J Biol Chem. 2011 Mar 25;286(12):10864-75. doi: 10.1074/jbc.M110.155002. Epub 2010 Dec 6.

40.

Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion.

Verbalis JG.

Endocrinol Nutr. 2010 May;57 Suppl 2:30-40. doi: 10.1016/S1575-0922(10)70020-6. Review.

PMID:
21130960
41.

Sex differences in vasopressin V₂ receptor expression and vasopressin-induced antidiuresis.

Liu J, Sharma N, Zheng W, Ji H, Tam H, Wu X, Manigrasso MB, Sandberg K, Verbalis JG.

Am J Physiol Renal Physiol. 2011 Feb;300(2):F433-40. doi: 10.1152/ajprenal.00199.2010. Epub 2010 Dec 1.

42.

Conivaptan: Evidence supporting its therapeutic use in hyponatremia.

Li-Ng M, Verbalis JG.

Core Evid. 2010 Jun 15;4:83-92.

43.

Brain volume regulation in response to changes in osmolality.

Verbalis JG.

Neuroscience. 2010 Jul 28;168(4):862-70. doi: 10.1016/j.neuroscience.2010.03.042. Epub 2010 Apr 24. Review.

PMID:
20417691
44.

Oral tolvaptan is safe and effective in chronic hyponatremia.

Berl T, Quittnat-Pelletier F, Verbalis JG, Schrier RW, Bichet DG, Ouyang J, Czerwiec FS; SALTWATER Investigators.

J Am Soc Nephrol. 2010 Apr;21(4):705-12. doi: 10.1681/ASN.2009080857. Epub 2010 Feb 25. Erratum in: J Am Soc Nephrol. 2010 Aug;21(8):1407.

45.

Hyponatremia-induced osteoporosis.

Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA, Resnick HE.

J Bone Miner Res. 2010 Mar;25(3):554-63. doi: 10.1359/jbmr.090827.

46.

Acute changes in arginine vasopressin, sweat, urine and serum sodium concentrations in exercising humans: does a coordinated homeostatic relationship exist?

Hew-Butler T, Noakes TD, Soldin SJ, Verbalis JG.

Br J Sports Med. 2010 Aug;44(10):710-5. doi: 10.1136/bjsm.2008.051771. Epub 2008 Sep 18.

47.

Acute changes in endocrine and fluid balance markers during high-intensity, steady-state, and prolonged endurance running: unexpected increases in oxytocin and brain natriuretic peptide during exercise.

Hew-Butler T, Noakes TD, Soldin SJ, Verbalis JG.

Eur J Endocrinol. 2008 Dec;159(6):729-37. doi: 10.1530/EJE-08-0064. Epub 2008 Sep 15.

PMID:
18794210
48.

Changes in plasma arginine vasopressin concentrations in cyclists participating in a 109-km cycle race.

Hew-Butler T, Dugas JP, Noakes TD, Verbalis JG.

Br J Sports Med. 2010 Jun;44(8):594-7. doi: 10.1136/bjsm.2008.049742. Epub 2008 Jul 15.

PMID:
18628357
49.

Osmotic and nonosmotic regulation of arginine vasopressin during prolonged endurance exercise.

Hew-Butler T, Jordaan E, Stuempfle KJ, Speedy DB, Siegel AJ, Noakes TD, Soldin SJ, Verbalis JG.

J Clin Endocrinol Metab. 2008 Jun;93(6):2072-8. doi: 10.1210/jc.2007-2336. Epub 2008 Mar 18.

50.

Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007.

Hew-Butler T, Ayus JC, Kipps C, Maughan RJ, Mettler S, Meeuwisse WH, Page AJ, Reid SA, Rehrer NJ, Roberts WO, Rogers IR, Rosner MH, Siegel AJ, Speedy DB, Stuempfle KJ, Verbalis JG, Weschler LB, Wharam P.

Clin J Sport Med. 2008 Mar;18(2):111-21. doi: 10.1097/JSM.0b013e318168ff31. No abstract available.

PMID:
18332684

Supplemental Content

Loading ...
Support Center